Association of Elevated Plasma Homocysteine Level with Restenosis and Clinical Outcomes After Percutaneous Coronary Interventions: a Systemic Review and Meta-analysis

被引:16
作者
Zhang, Zhipeng [1 ]
Xiao, Shan [2 ]
Yang, Changqiang [1 ]
Ye, Runyu [1 ]
Hu, Xianjin [1 ]
Chen, Xiaoping [1 ]
机构
[1] Sichuan Univ, Dept Cardiol, West China Hosp, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Day Surg Ctr, Chengdu 610041, Sichuan, Peoples R China
关键词
Homocysteine; Restenosis; Percutaneous coronary intervention; Meta-analysis; IN-STENT RESTENOSIS; RISK-FACTOR; BALLOON ANGIOPLASTY; DIABETES-MELLITUS; IMPACT; FOLATE; VITAMIN-B-12; MECHANISMS; DISEASE; INJURY;
D O I
10.1007/s10557-019-06866-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeWe conducted this systemic review and meta-analysis to investigate the association between elevated plasma homocysteine (Hcy) levels and recurrent restenosis and clinical outcomes after percutaneous coronary intervention (PCI).MethodsPubMed, EMBASE, and Web of Science were systematically searched prior to May 2018. Studies evaluating the association between plasma Hcy levels and the occurrence of restenosis, major adverse cardiac events (MACE), all-cause mortality, cardiac death, non-fatal myocardial infarction (MI), and target lesion revascularization were identified.ResultsA total of 19 articles with 4340 participants were identified. Higher Hcy levels were not associated with an increased risk of restenosis (relative risk (RR)=1.10, 95% CI 0.90-1.33). Hcy levels in the restenosis group were not significantly higher than in the non-restenosis group (weighted mean difference=0.70, 95% CI -0.23-1.63). Subgroup analysis revealed that higher Hcy levels were not associated with restenosis after stenting but appeared to increase the risk of restenosis after angioplasty. Elevated Hcy levels increased the risk of all-cause mortality by an average of 3.19-fold (RR=3.19, 95% CI 1.90-5.34, P=0.000), the risk of MACE by 1.51-fold (RR=1.51, 95% CI 1.23-1.85, P=0.000), and the risk of cardiac death by 2.76-fold (RR=2.76, 95% CI 1.44-5.32, P=0.000) but appeared not to increase the risk of non-fatal MI (RR=1.36, 95% CI 0.89-2.09).ConclusionsOur meta-analysis suggests that although there is no clear association between higher Hcy levels and restenosis following stent implantation, higher Hcy levels appeared to increase the risk of restenosis after coronary angioplasty and also increased the risk of all-cause mortality, MACE, and cardiac death after PCI.Registration DetailsThe protocol of this meta-analysis was registered on PROSPERO (CRD42018096466). (http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018096466).
引用
收藏
页码:353 / 361
页数:9
相关论文
共 48 条
[1]   Folate, vitamin B12 and total homocysteine levels in Arab adolescent subjects: Reference ranges and potential determinants [J].
Akanji, A. O. ;
Thalib, L. ;
Al-Isa, A. N. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (10) :900-906
[2]  
[Anonymous], MARMARA MED J
[3]  
[Anonymous], HEART LUNG CIRC
[4]   Effect of folic acid supplementation on risk of cardiovascular diseases - A meta-analysis of randomized controlled trials [J].
Bazzano, Lydia A. ;
Reynolds, Kristi ;
Holder, Kevin N. ;
He, Jiang .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (22) :2720-2726
[5]   Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease [J].
Bleie, O. ;
Semb, A. G. ;
Grundt, H. ;
Nordrehaug, J. E. ;
Vollset, S. E. ;
Ueland, P. M. ;
Nilsen, D. W. T. ;
Bakken, A. M. ;
Refsum, H. ;
Nygard, O. K. .
JOURNAL OF INTERNAL MEDICINE, 2007, 262 (02) :244-253
[6]   Postinterventional homocysteine levels: Failure as a predictive biomarker of in-stent restenosis [J].
Breuckmann, F ;
Naber, C ;
Beckert, J ;
Schmermund, A ;
Haude, M ;
Baumgart, D ;
Erbel, R .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 108 (01) :20-25
[7]   Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment [J].
Buccheri, Dario ;
Piraino, Davide ;
Andolina, Giuseppe ;
Cortese, Bernardo .
JOURNAL OF THORACIC DISEASE, 2016, 8 (10) :E1150-E1162
[8]   Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study [J].
Chen, Ching-Yu Julius ;
Yang, Tzu-Ching ;
Chang, Christopher ;
Lu, Shao-Chun ;
Chang, Po-Yuan .
BMC CARDIOVASCULAR DISORDERS, 2018, 18
[9]   Association between serum total homocysteine and arterial stiffness in adults: a community-based study [J].
Chen, Lulu ;
Wang, Binyan ;
Wang, Jiancheng ;
Ban, Qianyun ;
Wu, Hongxu ;
Song, Yun ;
Zhang, Jingping ;
Cao, Jingjing ;
Zhou, Ziyi ;
Liu, Lishun ;
Cao, Tianyu ;
Gao, Lan ;
Guo, Huiyuan ;
Zhang, Tao ;
Tang, Genfu ;
Huang, Xiao ;
Zhang, Yan ;
Li, Jianping ;
Huo, Yong ;
Cheng, Xiaoshu ;
Zang, Tonghua ;
Xu, Xiping ;
Zhang, Hao ;
Qin, Xianhui .
JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (04) :686-693
[10]   Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis [J].
Clarke, R ;
Collins, R ;
Lewington, S ;
Donald, A ;
Alfthan, G ;
Tuomilehto, J ;
Arnesen, E ;
Bonaa, K ;
Blacher, J ;
Boers, GHJ ;
Bostom, A ;
Bots, ML ;
Grobee, DE ;
Brattström, L ;
Breteler, MMB ;
Hofman, A ;
Chambers, JC ;
Kooner, JS ;
Coull, BM ;
Evans, RW ;
Kuller, LH ;
Evers, S ;
Folsom, AR ;
Freyburger, G ;
Parrot, F ;
Genst, J ;
Dalery, K ;
Graham, IM ;
Daly, L ;
Hoogeveen, EK ;
Kostense, PJ ;
Stehouwer, CDA ;
Hopknis, PN ;
Jacques, P ;
Selhub, J ;
Luft, FC ;
Jungers, P ;
Lindgren, A ;
Lolin, YI ;
Loehrer, F ;
Fowler, B ;
Mansoor, MA ;
Malinow, MR ;
Ducimetiere, P ;
Nygard, O ;
Refsum, H ;
Vollset, SE ;
Ueland, PM ;
Omenn, GS ;
Beresford, SAA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2015-2022